GRI Bio's total assets for Q3 2025 were $4.78M, a decrease of -15.74% from the previous quarter. GRI total liabilities were $2.79M for the fiscal quarter, a 18.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.